US 10316316
Compositions for targeted delivery of siRNA
granted A61KA61K31/713A61K47/32
Quick answer
US patent 10316316 (Compositions for targeted delivery of siRNA) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/713, A61K47/32, A61K47/549, A61K47/60